NVIDIA's 13F just tripled — without buying a single share.

$63.4B across eight public names after the SpaceX conversion and Intel's run — plus a $51B shadow book of private stakes that is still growing.
13F Portfolio Value
$63.44B
8 positions · as of 6/30/26
↑ +$45.07B QoQ
Quarter-over-Quarter Δ
+245%
from $18.37B (Q1 '26)
0 bought · 0 sold · 1 conversion
Non-Marketable Equity MV
$51.16B
Balance sheet, 10-Q Jul 26, 2026 · private + illiquid
+$28.9B since Jan 25
Largest Single Stake
$29.99B
Intel Corp · 47.3% of 13F book
+$25.0B on a $5B cost
Section 01 · Full Position Table

Every public position, 5 quarters, side-by-side.

Values in $ millions ($M) at quarter-end market value, taken line-by-line from the SEC information tables. Column totals equal the SEC-reported 13F aggregate to the dollar. "—" = pre-hold, "$0" = post-exit.

Company Tkr Sector Q-4 · 6/30/25 Q-3 · 9/30/25 Q-2 · 12/31/25 Q-1 · 3/31/26 Q0 · 6/30/26 Move
Intel Corp INTC Semiconductors — — $7,925 $9,478 $29,989 Hold
Space Exploration Technologies SPCX Space · Starlink · xAI — — — — $20,976 New
CoreWeave Inc CRWV AI cloud infra $3,959 $3,322 $1,739 $3,658 $4,700 Hold
Coherent Corp COHR Optical networking — — — $1,855 $3,072 Hold
Nokia Oyj NOK Telecom / RAN — — $1,077 $1,338 $2,210 Hold
Synopsys Inc SNPS EDA / chip design — — $2,265 $1,912 $2,151 Hold
Nebius Group NV NBIS AI cloud infra (EU) $66 $134 $100 $124 $329 Hold
Generate Biomedicines GENB AI drug discovery — — — $10 $14 Hold
Arm Holdings plc ARM Semi IP / CPU arch $178 $156 $0 $0 $0 Exited
Applied Digital Corp APLD Neocloud / data ctrs $78 $177 $0 $0 $0 Exited
Recursion Pharmaceuticals RXRX AI biotech $39 $38 $0 $0 $0 Exited
WeRide Inc WRD Autonomous driving (CN) $14 $17 $0 $0 $0 Exited
SEC-reported 13F total $4,333 $3,844 $13,105 $18,374 $63,440

Reconciliation note. Every cell is the SEC information-table value for that CUSIP; each column sums to the cover-page tableValueTotal exactly ($4,333,080,800 · $3,843,681,339 · $13,104,819,528 · $18,374,354,150 · $63,439,974,569). Share counts: Intel 214,776,632 (unchanged since Q4 '25); SpaceX 122,764,805; CoreWeave 47,213,353 (unchanged since the Q1 '26 add); Coherent 7,788,161; Nokia 166,389,351 ADRs; Synopsys 4,821,717; Nebius 1,190,476; Generate 833,325. Not a single share count changed between Q1 and Q2 2026. No 13F-HR/A amendments have been filed for any of the five periods, so no confidential-treatment positions have been unmasked. The July 2026 edition (Teardown No. 04, Q1 2026 cutoff) is preserved unchanged; it triangulated the smaller positions (Nebius, Applied Digital, Arm, Recursion, WeRide) from share counts × prices, and those cells are replaced here by filed values — Nebius in particular was understated by roughly half. Accession numbers: 0001045810-25-000199 (Q2'25), -25-000219 (Q3'25), -26-000011 (Q4'25), -26-000042 (Q1'26), -26-000065 (Q2'26).

Section 02 · Top Holdings, Ranked

Two names carry 80% of the 13F book.

INTC + SPCX = 80.3% of the portfolio; the top six = 99.5%. Nebius ($329M) and Generate ($14M) are the tail. Cost bases from NVIDIA's announced deal terms; market values from the filing.

01

Intel Corp

NASDAQ: INTC · 47.3% of book
Market Value
$29,989M
Shares
214.78M
Cost Basis
$23.28/sh
Unrealized Gain
+$25.0B · 6.0×
The $5B September 2025 check is now worth $30B. Implied price $139.63 at June 30, up from $44.13 at March 31, as Intel's foundry turnaround (a 24% single-day jump in April, Foxconn partnership in June, Data Center & AI revenue +59% in Q2) re-rated the stock. Share count has not moved in three filings. Part of the position sits in a lock-up through December 2027.
02

Space Exploration Technologies

NASDAQ: SPCX · 33.1% of book
Market Value
$20,976M
Shares
122.76M Class A
Cost Basis
~$10B (xAI, Jan '26)
Implied price
$170.86 · IPO $135
New to the 13F, but not a purchase. NVIDIA put ~$10B into xAI's $20B Series E in January 2026. SpaceX acquired xAI in an all-stock deal in February, converting that stake into SpaceX Class A, and the June 12 IPO made it a Section 13(f) security. It arrives at roughly 2× cost and subject to the staggered pre-IPO lock-up. By the Aug 14 filing date SpaceX had fallen to $140, trimming the position to ~$17B.
03

CoreWeave Inc

NASDAQ: CRWV · 7.4% of book
Market Value
$4,700M
Shares
47.21M
Q1 Add Price
$87.20/sh
Implied price
$99.54 · +28% QoQ
Unchanged since the January 2026 doubling (+22.94M shares at $87.20, ~$2B) that came with the expanded $6.3B unsold-capacity backstop through April 2032. Dollar exposure rose $1.0B in Q2 on price alone. Originally a $100M seed check in 2023; the seed tranche is sitting on a multiple that dwarfs anything else in the book.
04

Coherent Corp

NYSE: COHR · 4.8% of book
Market Value
$3,072M
Shares
7.79M
Cost Basis
~$2B · ~$257/sh
Unrealized
+$1.07B · +66% QoQ
Underwater in March, up 50% by June. The ~$2B Q1 2026 position (800G/1.6T optical transceivers for AI interconnect) was carried at $1.86B at March 31 and $3.07B at June 30 — implied $394 vs ~$257 cost. Still the only one of the three $2B March optical bets (Coherent, Marvell, Lumentum) that shows on the 13F; the other two are structured and sit in the callout.
05

Nokia Oyj

NYSE: NOK · 3.5% of book
Market Value
$2,210M
Shares
166.39M ADR
Cost Basis
~$6.01/sh
Unrealized
+$1.2B · 2.2×
The $1B October 2025 AI-RAN stake has more than doubled. Implied $13.28 at June 30 vs $8.04 at March 31. Co-developing radio-access reference designs on Grace + BlueField; the telecom-silicon socket NVIDIA is taking from Marvell and Broadcom. No change in share count.
06

Synopsys Inc

NASDAQ: SNPS · 3.4% of book
Market Value
$2,151M
Shares
4.82M
Cost Basis
$414.79/sh
Unrealized
+$151M · back above water
The December 2025 $2B stake (taken after SNPS fell on a weak print) was the book's only underwater core holding in March; it crossed back above cost in Q2 at an implied $446. EDA / chip-design workflow integration (Ansys + CUDA-Q). Nebius — $329M of common, up 166% QoQ — drops to seventh; its real exposure is the $2B of pre-funded warrants in the callout.
Section 03 & 04 · Latest-Quarter Trades

A $45B quarter with no trades.

Adds show new positions and any >25% additions to existing holdings. Exits show peak share count and last reported value, flagging any position held under four quarters. Q2 2026 had one new line (by conversion) and no sales; the mark-to-market moves are listed so the quarter isn't read as a buying spree.

Section 03 · Adds

New positions & >25% additions

Q2 2026 (period ending 6/30/26)
Space Exploration Technologies $20,976M
New · via conversion 122.76M Class A shares. Not an open-market buy: the ~$10B xAI stake (Jan 2026) became SpaceX stock at the February merger and became 13F-reportable at the June 12 IPO. Enters the book at 33.1% in one quarter.
No share additions to existing positions 0 of 7
Hold Every legacy share count (Intel, CoreWeave, Coherent, Nokia, Synopsys, Nebius, Generate) is identical to the March 31 filing. The dollar moves below are price.
Intel Corp +$20,511M
Hold, mark-to-market +216% $44.13 → $139.63 on the foundry re-rating. The single largest quarterly value change of any corporate 13F position we track.
Coherent · Nokia · Nebius · CoreWeave +$3,334M
Hold, mark-to-market Coherent +$1,217M (+66%), Nokia +$872M (+65%), Nebius +$205M (+166%), CoreWeave +$1,042M (+28%). Synopsys +$239M (+13%), Generate +$4M. Every holding rose.
Section 04 · Exits

Positions closed & short-tenure flags

None in Q2 2026 · last exits were the Q4 '25 cleanup, still inside the five-quarter window
Arm Holdings plc Peak $178M · Last $156M
Peak 1.10M sh @ 6/30/25. Full exit in Q4 2025 despite the Nvidia–Meta pact expanding Arm CPU use in data centers. Ended the 2020-vintage Arm ownership relationship.
Applied Digital Corp Peak $177M · Last $177M
Peak 7.72M sh @ 9/30/25. Exited in Q4 2025 as APLD rallied on hyperscaler lease news. NVIDIA's neocloud exposure narrowed to CoreWeave + Nebius — then Q2 added SpaceX, which owns a hyperscale compute business of its own.
Recursion Pharmaceuticals Peak $62M · Last $38M
Held ~5 quarters; 7.71M sh. Lost roughly 40% over the life of the position. Replaced thematically by the Generate Biomedicines probe, which is up 36% since it was taken.
WeRide Inc Peak $17M · Last $17M <4Q hold
1.74M sh, held Q4 '24 → Q3 '25 (four quarters, borderline). China-listed autonomous-driving stake exited with de minimis P&L. NVIDIA's only China-tech line, now closed for three filings.
Section 05 · Portfolio Themes

Five theses — one supply chain, now with an AI lab on top.

Every 13F position (and every off-13F structured deal) maps to a layer of the AI stack NVIDIA is trying to accelerate or secure. The Q2 change is that the lab layer — previously entirely private — now has a $21B public line. Themes sum to the SEC total.

Theme 01 · Silicon Alliances

Owning the CPU + foundry + EDA layer

$32.14B · 50.7% of book
Intel is now a foundry bet as much as a CPU partnership — the stock's 2026 run is the market pricing a second source for advanced manufacturing. Synopsys is the design layer upstream of the GPU. Capacity insurance, marked up 6×.
  • Intel Corp $29,989M
  • Synopsys Inc $2,151M
Theme 02 · Frontier Lab, Public

The xAI bet, now tradable

$20.98B · 33.1% of book
NVIDIA's lab stakes (OpenAI $30B, Anthropic up to $10B, xAI ~$10B) were all private. The SpaceX merger and IPO made one of them a listed security — the first time a frontier-lab position has appeared on any corporate 13F. Locked up, but marked daily.
  • Space Exploration Technologies $20,976M
Theme 03 · Networking & Optical

Interconnect is the new bottleneck

$5.28B · 8.3% of book
Coherent for 800G/1.6T optical inside the rack; Nokia for AI-RAN at the edge. Both more than doubled in value in two quarters. Marvell, Lumentum and the Corning warrants extend the same thesis off-13F.
  • Coherent Corp $3,072M
  • Nokia Oyj $2,210M
Theme 04 · Neocloud Backstop

Financing the GPU renters

$5.03B · 7.9% of book
CoreWeave & Nebius exist to buy NVIDIA GPUs and rent capacity; NVIDIA funds them and backstops unsold capacity. Add IREN's $2.1B of warrants (May) and the $3.3B of equity-method infrastructure financiers, and the circular-financing book is closer to $12B.
  • CoreWeave Inc $4,700M
  • Nebius Group (common only) $329M
Theme 05 · Off-13F Structured & Private

The book that still dwarfs the 13F's real-company lines

$51.16B · 10-Q, Jul 26, 2026
Non-marketable equity more than doubled again in six months despite $12.7B leaving for the 13F (the xAI → SpaceX conversion). OpenAI, Anthropic, Groq, the Nebius / Marvell / Lumentum structures, MediaTek converts and the pending Hugging Face purchase live here. Detailed below.
  • Balance sheet (Jul 26, 2026) $51,157M
  • Cumul. unrealized gain +$9.1B
  • Undrawn commitments $25.0B
Theme 06 · Biotech Probe + Exited Cluster

The tail, and what was pruned

$14M live · $0 exited
Generate Biomedicines ($14M, +36% since Q1) is the lone AI-drug-discovery probe after Recursion was cut. Applied Digital, Arm, Recursion and WeRide were all removed in Q4 '25 — a consolidation into fewer, larger, strategically-tied bets that Q2 '26 continued by doing nothing at all.
  • Generate Biomedicines $14M
  • Arm · Applied Digital Exited $156M · $177M
  • Recursion · WeRide Exited $38M · $17M
Section 05b · Off-13F Structured & Private Deals

The shadow portfolio: $51B on the balance sheet, $25B still to deploy.

These positions live in Note 6 of NVDA's Q2 FY27 10-Q ("Non-marketable Equity Securities", quarter ended July 26, 2026) or in instruments — pre-funded warrants, convertibles, commitments, a pending acquisition — that don't appear on the 13F. Sources: 10-Q Note 6, 8-K of Sep 2, 2026, and Tier-1 outlets (CNBC, Reuters, Bloomberg, The Information).

Investee / Deal Instrument Size (Approx) Status & Source
OpenAI
Foundation-model lab
Equity, part of the $122B round $30B Announced Feb 27, closed Mar 31, 2026, under the Sep 2025 up-to-$100B framework · CNBC, Reuters
Anthropic
Foundation-model lab
Series G equity ($380B post-money) Up to $10B February 2026 · exact deployed amount not disclosed · CNBC, TradingKey
xAI → SpaceX
Graduated to the 13F
Series E → SPCX Class A common ~$10B → $21.0B Jan 2026 stake, converted Feb 2026, 13F-reportable from Jun 12 IPO · the $12.3B Q2 reclassification out of non-marketable · 10-Q Note 6, CNBC
Hugging Face
Open-model platform · 18M developers
Acquisition (definitive agreement) $11.9B + $1.0B retention Signed Sep 2, 2026 · closing expected H1 2027 pending regulatory approval · NVIDIA's largest-ever deal · 8-K Sep 2, 2026
MediaTek
Custom silicon partner
Convertible bonds $3.5B Announced Aug 31, 2026 · off-13F until converted · TradingKey
Nebius Group
EU neocloud, in addition to $329M common
Pre-funded warrants $2.0B March 2026 · ~9.3% beneficial stake per July 13G, but only 1.19M common on the 13F · 10-Q, SEC 13G
Marvell · Lumentum
Custom silicon · optical
Structured equity (not common) $2.0B + $2.0B March 2026, announced alongside Coherent · neither appears on the 13F · Reuters, Bloomberg
IREN · Corning
Data-center power · optical fiber
Warrants (30M sh @ $70 · $500M) + procurement Up to $2.1B · up to $3.2B May 2026 · warrants are not 13(f) securities until exercised · Benzinga, company releases
Poolside · Cloverleaf
Coding-model lab · data-center developer
$1B equity + $6B licensing · minority equity ~$1B · undisclosed August 2026 · TradingKey
Groq Inc
Inference-silicon startup
Non-exclusive tech license $2.9B paid in H1 FY27 $986M of consideration still accrued at Jul 26 (from $3.9B in Jan) · a license, not equity · 10-Q cash-flow statement
In talks
Thinking Machines Lab · Perplexity
Equity ~$2.5B · undisclosed Reported Sep 3 and Aug 2026 by The Information · not yet in any filing · TradingKey
Infrastructure financiers
Equity-method investments
LP interests $3.3B carried VIE maximum loss exposure $4.7B incl. committed amounts · 10-Q Note 6
Total equity commitments
Aggregate undrawn
AI model makers, infrastructure financiers $25.0B $18B rest of FY27 · $3B FY28 · $2B FY29 · $2B FY30 · 10-Q Note 6
Lock-up equity
Publicly-held with transfer restrictions
Short-term + long-term lock-ups $36.9B + $5.0B At Jul 26, 2026 (vs $10.5B + $4.8B in Jan) · long-term portion locked through Dec 2027 · 10-Q Note 5

Reconciliation. The 10-Q rolls privately-held securities from $22.3B (Jan 25) to $47.9B (Jul 26): +$31.0B net additions, +$7.5B unrealized gains, −$12.7B reclassified "following public market trading" — the xAI stake becoming SpaceX stock — and −$0.2B of impairments; the balance-sheet line including equity-method stakes is $51.2B. Cumulative unrealized gains on the private book are $9.1B, from $0.7B a year earlier. Publicly-held equity is carried at $47.7B at Jul 26 — $36.9B Level 1 plus $10.8B Level 2, the latter almost certainly the SpaceX shares marked at a lock-up discount — versus the 13F's $63.4B at Jun 30; the gap is that discount plus four weeks of price moves. The equity book now moves NVIDIA's own P&L: $7.8B of gains from equity securities in Q2 FY27 and $23.7B in the first half sit in GAAP other income and explain why GAAP EPS ($2.46) ran ahead of non-GAAP ($2.22). With $25B still committed and Hugging Face to close, the shadow book is on track to pass $75B during FY27.

Section 06 · Prompt Restated (for reproducibility)
HTML rpt [NVDA] port.
FETCH:(a)EDGAR CIK sec.gov/cgi-bin/browse-edgar?action=getcompany&company={CO}&type=13F.No13F-HR→say in lede,pivot 10-K/10-Q/8-K equity disc,same shape.(b)5 latest 13F-HR accnos.Rows valuesider.com/guru/{slug}/portfolio/{YYYY}/{Q}?page={N},paginate til all caught.Totals 13f.info/manager/{CIK}-{slug}.NEVER fetch 13f.info detail(JS).NEVER fetch SEC subdocs(dyn URLs blocked).(c)Latest 10-K Note4/5"Inv equity sec":cost/MV/own%/div per name+struct instr(pref/warr/conv).Not in 13F.(d)Σrows/qtr=SEC total±round.Δ→chk 13F-HR/A amend(may reveal confid-treat pos).Footnote recon.(e)Priv/foreign/pre-IPO:xchk press(Nikkei/BBG/Reuters/IR/Fm4/13G/13D).Incl only if in 10-K OR Tier-1 outlet.
TOP:brand strip,hero,1p lede,4 stat cards(13F val,Q/QΔ,non-mkt eq MV,largest stake).
§(ORDER IS FIXED):(1)Full tbl[IMMED AFTER STATS],every pos×5Q:Co|Tkr|Sec|Q-4|Q-3|Q-2|Q-1|Q0($M,$prefix every cell)|Move(Hold/New/Added/Trim/Exited).Totals row=SEC.Incl mid-per exits."—"=pre-hld,"$0"=post-exit.(2)Top hldgs ranked cards:val/sh/cost/rationale.(3&4)Adds+Exits latest Q side-by-side:adds=new+>25% adds;exits=peak sh+last val,flag<4Q hlds.(5)4-6 themes cards:$tot+per-name+1-ln thesis.Off-13F struct deals=sep callout.(6)Restate prompt @base.
STY:bg#FBFAF6 ink#0F0F10 sky#5DCDF1 sage#7DCFB6 honey#FFB36B.H=Recoleta(Fraunces fb),body=Manrope,nums=JBMono tab.Wht cards r12 soft shdw,L color-bar per theme.Pills Hold/New/Added/Trim/Exited.Resp 1col<900px.
Evolve Financial · Portfolio Teardown Series · Numbers Ledger sources: SEC EDGAR (13F-HR information tables, accession nos. listed), NVDA 10-Q Q2 FY27 (Jul 26, 2026) Notes 5–7, NVDA 8-K Sep 2, 2026 (Hugging Face), Q2 FY27 earnings release (Aug 26, 2026), CNBC, Reuters, Bloomberg, The Information via TradingKey, Benzinga, Motley Fool. Published Oct 16, 2026. Successor to Teardown No. 04 (Jul 10, 2026).
© 2026 Balaji Bhaskar · Not investment advice · Verify with primary filings before acting